CHDH
Basic information
Region (hg38): 3:53812335-53846419
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHDH gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 33 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 33 | 6 | 2 |
Variants in CHDH
This is a list of pathogenic ClinVar variants found in the CHDH region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-53817851-T-A | not specified | Uncertain significance (Oct 14, 2023) | ||
3-53817890-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
3-53817895-A-G | not specified | Uncertain significance (Feb 05, 2024) | ||
3-53817967-G-T | not specified | Uncertain significance (Mar 15, 2024) | ||
3-53817995-C-T | not specified | Uncertain significance (Feb 16, 2023) | ||
3-53818026-G-C | Likely benign (Aug 08, 2018) | |||
3-53818046-C-T | not specified | Uncertain significance (Jul 06, 2022) | ||
3-53818060-A-G | not specified | Uncertain significance (Nov 07, 2023) | ||
3-53818071-C-G | not specified | Uncertain significance (Jun 10, 2022) | ||
3-53818111-T-C | not specified | Uncertain significance (Jan 29, 2024) | ||
3-53818174-C-T | not specified | Uncertain significance (Oct 13, 2021) | ||
3-53818940-G-T | not specified | Uncertain significance (May 11, 2022) | ||
3-53819021-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
3-53819558-C-T | not specified | Uncertain significance (Mar 14, 2024) | ||
3-53819561-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
3-53819608-G-A | not specified | Uncertain significance (Oct 22, 2021) | ||
3-53819633-G-A | not specified | Uncertain significance (Apr 01, 2024) | ||
3-53819670-C-G | not specified | Likely benign (Sep 20, 2023) | ||
3-53820477-T-C | not specified | Uncertain significance (Oct 10, 2023) | ||
3-53820515-C-T | not specified | Likely benign (May 27, 2022) | ||
3-53820516-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
3-53820551-C-T | not specified | Likely benign (Jul 14, 2021) | ||
3-53820606-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
3-53821737-T-C | not specified | Uncertain significance (Oct 27, 2022) | ||
3-53822498-C-G | not specified | Uncertain significance (Nov 22, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHDH | protein_coding | protein_coding | ENST00000315251 | 7 | 34056 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000168 | 0.967 | 125673 | 0 | 75 | 125748 | 0.000298 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.02 | 321 | 377 | 0.852 | 0.0000254 | 3781 |
Missense in Polyphen | 136 | 171.52 | 0.79291 | 1620 | ||
Synonymous | 0.352 | 161 | 167 | 0.965 | 0.0000123 | 1224 |
Loss of Function | 1.99 | 13 | 23.4 | 0.555 | 0.00000115 | 244 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000813 | 0.000812 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.0000555 | 0.0000544 |
Finnish | 0.0000965 | 0.0000924 |
European (Non-Finnish) | 0.000367 | 0.000343 |
Middle Eastern | 0.0000555 | 0.0000544 |
South Asian | 0.000302 | 0.000294 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Pathway
- Glycine, serine and threonine metabolism - Homo sapiens (human);S-Adenosylhomocysteine (SAH) Hydrolase Deficiency;Methionine Metabolism;Methionine Adenosyltransferase Deficiency;Glycine N-methyltransferase Deficiency;Hypermethioninemia;Methylenetetrahydrofolate Reductase Deficiency (MTHFRD);Betaine Metabolism;Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type;sarcosine oncometabolite pathway ;Cystathionine Beta-Synthase Deficiency;Methionine De Novo and Salvage Pathway;One carbon metabolism and related pathways;choline degradation;Metabolism of amino acids and derivatives;Metabolism;Choline catabolism;superpathway of choline degradation to L-serine;Glycine, serine, alanine and threonine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.177
Intolerance Scores
- loftool
- 0.581
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.51
Haploinsufficiency Scores
- pHI
- 0.152
- hipred
- N
- hipred_score
- 0.343
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.945
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chdh
- Phenotype
- cellular phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- glycine betaine biosynthetic process from choline;choline catabolic process;oxidation-reduction process
- Cellular component
- mitochondrial inner membrane
- Molecular function
- protein binding;choline dehydrogenase activity;flavin adenine dinucleotide binding